MemoApp – A Therapeutic Ecosystem at Home
From a Silent Disease to a Therapeutic Revolution, MemoApp’s Unique Care Approach
Stage 1: Dementia – A Disease Equal to the Toughest of Illnesses
When we speak of severe illnesses, names like cancer, stroke, heart failure, or multiple sclerosis immediately come to mind. These diseases dominate public awareness, attract massive research funding, and are widely recognized as life-threatening conditions.But alongside them lies a quieter, more elusive, yet equally devastating illness: dementia.Alzheimer’s disease, the most common form of dementia, is consistently ranked as one of the leading causes of dependency, long-term hospitalization, and emotional suffering. Unlike many other illnesses, it is nearly always progressive and irreversible.It is not merely a disease of aging—it is a systemic condition that affects memory, identity, daily function, and basic human dignity.
Stage 2: Dementia and Alzheimer’s – The Pandemic of the 21st Century
According to the World Health Organization (WHO), over 55 million people worldwide live with dementia, with 10 million new cases emerging annually. In Israel alone, it is estimated that over 200,000 individuals are affected—numbers expected to double within a decade.The global cost of dementia care has already surpassed one trillion USD per year, projected to reach two trillion by 2030.Beyond the financial burden lies a profound human cost: families collapse, caregivers burn out, communities search for answers.As stated in a UNDP report: “Dementia is one of the most urgent challenges of our time, requiring innovative responses at the individual, community, and national levels.”
Stage 3: The Seven Stages of Dementia – A Race Against Time
Dementia has a well-documented progression, commonly divided into seven stages (based on Dr. Barry Reisberg’s GDS scale):
Stage 4: Common Care Methods – But No Unified Solution
Current approaches to dementia care include:
Stage 5: A New Therapeutic Paradigm – The MemoApp Breakthrough
In response to this unmet need, MemoApp emerged as a pioneering therapeutic approach—a solution built from the ground up based on field research, family involvement, and clinical observations.Our key discovery:In early dementia stages, the most critical loss is episodic memory—the ability to recall events, people, and daily routines. This leads to confusion, anxiety, insecurity, and dependency.
At the same time, research and observation revealed another truth:People with cognitive impairments have an intrinsic, often unconscious, drive to help themselves and adapt—with the right tools.
MemoApp was born from this dual insight:
MemoApp is far more than a tech product—it is a therapeutic ecosystem, designed around the user.
Stage 7: The Road Ahead – AI, Sensors, and a Vision for Humanity
MemoApp is constantly evolving:
MemoApp is committed to leading that transformation.
When we speak of severe illnesses, names like cancer, stroke, heart failure, or multiple sclerosis immediately come to mind. These diseases dominate public awareness, attract massive research funding, and are widely recognized as life-threatening conditions.But alongside them lies a quieter, more elusive, yet equally devastating illness: dementia.Alzheimer’s disease, the most common form of dementia, is consistently ranked as one of the leading causes of dependency, long-term hospitalization, and emotional suffering. Unlike many other illnesses, it is nearly always progressive and irreversible.It is not merely a disease of aging—it is a systemic condition that affects memory, identity, daily function, and basic human dignity.
Stage 2: Dementia and Alzheimer’s – The Pandemic of the 21st Century
According to the World Health Organization (WHO), over 55 million people worldwide live with dementia, with 10 million new cases emerging annually. In Israel alone, it is estimated that over 200,000 individuals are affected—numbers expected to double within a decade.The global cost of dementia care has already surpassed one trillion USD per year, projected to reach two trillion by 2030.Beyond the financial burden lies a profound human cost: families collapse, caregivers burn out, communities search for answers.As stated in a UNDP report: “Dementia is one of the most urgent challenges of our time, requiring innovative responses at the individual, community, and national levels.”
Stage 3: The Seven Stages of Dementia – A Race Against Time
Dementia has a well-documented progression, commonly divided into seven stages (based on Dr. Barry Reisberg’s GDS scale):
- Stage 1 – No Cognitive Decline (Normal Functioning)
- Stage 2 – Age-Related Forgetfulness
- Stage 3 – Mild Cognitive Impairment (MCI)
- Stage 4 – Early-Stage Dementia
- Stage 5 – Moderate Dementia
- Stage 6 – Severe Dementia with Functional Loss
- Stage 7 – Terminal Dementia and End-of-Life
Stage 4: Common Care Methods – But No Unified Solution
Current approaches to dementia care include:
- Pharmacological treatments (e.g., Donepezil, Memantine) to slow decline.
- Supportive therapies – such as art, music, or animal-assisted therapy.
- Physical exercise – adapted to preserve mental and physical function.
- Psychological counseling and social work support.
- Specialized diets – rich in omega-3s and antioxidants.
- Basic assistive technologies – like reminder watches or care apps.
- Long-term care facilities and day centers.
Stage 5: A New Therapeutic Paradigm – The MemoApp Breakthrough
In response to this unmet need, MemoApp emerged as a pioneering therapeutic approach—a solution built from the ground up based on field research, family involvement, and clinical observations.Our key discovery:In early dementia stages, the most critical loss is episodic memory—the ability to recall events, people, and daily routines. This leads to confusion, anxiety, insecurity, and dependency.
At the same time, research and observation revealed another truth:People with cognitive impairments have an intrinsic, often unconscious, drive to help themselves and adapt—with the right tools.
MemoApp was born from this dual insight:
- The profound loss of internal structure
- And the hidden human urge to lean on external cognitive scaffolding
MemoApp is far more than a tech product—it is a therapeutic ecosystem, designed around the user.
- A large smart screen is placed in the user’s home—becoming a window to clarity.
- The screen displays daily schedules, photos of loved ones, personal messages, medication reminders, and video calls with one-touch activation.
- Family members can remotely update content via a dedicated app—changes appear instantly on the screen.
- Content is personalized to the stage of dementia, the user’s digital literacy, and family needs.
Stage 7: The Road Ahead – AI, Sensors, and a Vision for Humanity
MemoApp is constantly evolving:
- AI integration for personalized content and interaction.
- Advanced sensors for tracking user activity, movement, and emotional state.
- Voice recognition and natural language processing for intuitive communication.
- Facial expression and video analysis modules for emotional monitoring.
- Crowdsourced insights from users and families to guide innovation.
MemoApp is committed to leading that transformation.
